Cytotherapy
Издатель: Elsevier · ISSN 1465-3249 · 58 статей
- Out of Specification frameworks may overestimate clinical risk: a lesson from commercial CAR-T products deviations
- Interferon γ MSC accumulation in the lungs is mediated by integrin α4β1 adhesion
- What Drives Investment in Cell and Gene Therapy? Evidence from a Global Investor Survey of 100 Investors
- Sustainable Point-of-Care Manufacturing of Cell and Gene Therapies: Operational, Regulatory and Economic Pathways for Implementation
- Drug or Medical Technology? China’s Dual-Track Regulation of Cell and Gene Therapy under State Council Order No. 818
- Safety, efficacy, and PK/PD of a BCMA-targeted CAR-NK cell therapy (LUCAR-B68) in relapsed/refractory multiple myeloma: a phase I study
- Clinical trials with Advanced Therapy Medicinal Products in Europe (2016–2025): the Regulators’ analysis
- Significant Differences in Infrastructure, Financing, and Workforce exist across Cell Therapy Manufacturing Facilities. A Report from BEST Collaborative.
- Clinical outcomes of CAR-T cell therapy in 21 patients with relapsed or refractory B-cell lymphoma involving the ileocecal region
- A call to action: Position papers from the FDA Cell Therapy Liaison Meeting (CTLM) Working Group
- Cytokine-Independent Proliferation of CAR-T cells: Bug or Feature?
- The Commercial Viability of Cell Therapy: We Cannot Continue to Accept the Status Quo
- Practical Guide for Bench-to-Bedside Translation of Adoptive Cell Therapies: A Case-Based Series
- The Spanish Approach to Supporting the Development of SoHO Preparations, ATMPs, and Other SoHO-Based Products Under the New EU Regulation
- Optimization of a serum-free and stroma-free induction system for large-scale generation of functional red blood cells from human hematopoietic stem cells
- Key Considerations for In Vitro Assessment of On- and Off-target/ Off-Disease Effects of Chimeric Antigen Receptor T-Cell Therapies
- Functional assessment reveals the properties of ABCG2-positive limbal stem cells derived from human pluripotent stem cells
- Cord blood regulatory T cells outperform adult and thymus Tregs in therapeutic potential for next-generation cell therapy
- Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research
- In vitro and in vivo antibacterial activity of the mesenchymal stem cell secretome against Escherichia coli colonization among infants
- Establishment and multisite evaluation of a MOLT-4 cell-based IL-2-independent growth assay to detect transformed cells in T-cell products
- iPSC-derived engineered immune cells: a therapeutic platform
- Compassionate and Emergency Use Cellular Therapy Products: Regulatory, Operational, and Quality Considerations
- Rapid epigenetic analysis for quantification of iPSC pluripotency from dried cell spots
- NIVOLUMAB-CONTAINING SALVAGE CHEMOTHERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA MAY IMPAIR STEM CELL MOBILIZATION
- A Genetically Engineered, Monoclonal, and Inducible Mesenchymal Stem Cell Platform with Controlled Proliferation and In Vivo Traceability
- Enhancing NK cell cytotoxicity with innate cell engagers as an alternative to CAR-NK cells
- Long-term 3D tumor spheroid cultures enable evaluation of durable effector T cell function in solid tumors
- IMPACT OF RUXOLITINIB ON VIRUS SPECIFIC-T LYMPHOCYTES: AN IN VITRO STUDY
- Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions